Competitive binding assays in prostate cancer PC3 cells showed that both nanoconstructs have a high affinity towards the GRPr; however, there was a significant contrast in the cell internalization behavior of the two radiolabeled nanoconstructs in the same cell line. This evidence concerns the gene GRPR and prostate carcinoma.